Chronic portal hypertension in the rat by triple-portal stenosing ligation

Journal of Investigative Surgery

Volumn 15, Issue 6, 2002, Pages 329-336

  Dieguez B ^a   Aller, M A ^a   Nava, M P ^a   Palma, M D ^a   Arias, J L ^b   Lopez L ^b   Arias, J ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

Author keywords

Collateral circulation; Portal hypertension; Rat

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; COLLATERAL CIRCULATION; INCIDENCE; KIDNEY MASS; LIVER WEIGHT; MALE; MESENTERIC VEIN; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; RAT; SPLEEN WEIGHT; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE; TESTIS WEIGHT; VEIN DISEASE; VEIN LIGATION;

ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HYPERTENSION, PORTAL; LIGATION; MALE; ORGAN SIZE; RATS; RATS, WISTAR; TESTIS;

EID: 0036873601     PISSN: 08941939     EISSN: None     Source Type: Journal    
DOI: 10.1080/08941930290086146     Document Type: Article

References (22)

1. Bosch J. Medical treatment of portal hypertension. Digestion. 1998;59:547-555.
2. Lebrec D. Pharmacological treatment of portal hypertension: Present and future. J Hepatol. 1998;28:896-907.
3. Iannitti DA, Henderson JM. Surgery in portal hypertension. Bailliere Clin Gastr. 1997;11:351-364.
4. Chojkjer M, Groszmann RJ. Measurement of portal-systemic shunting in the rat by using γ-labeled microspheres. Am J Physiol. 1981;240:G371-G375.
5. Bosch J, Pizcueta P, Feu F, Ferńandez M, García-Pagán JC. Pathophysiology of portal hypertension. Gastroenterol Clin North Am. 1992;21:1-14.
6. Groszmann RJ, Vorobioff J, Riley E. Measurement of splanchnic hemodynamics in portal hypertensive rats: Application of γ-labeled microspheres. Am J Physiol. 1982;242:G156-G160.
7. Sikuler E, Kravetz D, Groszmann RJ. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol. 1985;248:G618-G625.
8. Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic splanchnic circulation in portal-hypertensive rat model: A primary factor for maintenance of chronic portal hypertension. Am J Physiol. 1983;244:G52-G57.
9. Sikuler E, Groszmann RJ. Hemodynamic studies in long- and short-term portal hypertensive rats: The relation to systemic glucagon levels, Hepatology. 1986;6:414-418.
10. Lin HC, Soubrane O, Lebrec D. Prevention of portal hypertension and portosystemic shunts by early chronic administration of clonidine in conscious portal vein-stenosed rats. Hepatology. 1991;14:325-330.
11. w-nitro-L-arginine ameliorates portal systemic shunting in portal-hypertensive rats. Gastroenterology. 1993;105:1464-1470.
12. 4 levels in short-term prehepatic portal hypertension in rats. Dig Dis Sci. 2000;45:1865-1871.
13. Canty TG, Jauregizar E, Fernández-Cruz L. Experimental portal hypertension in the rat. J Pediatr Surg. 1980;115:819-826.
14. Halvorsen JF, Myking AO. Prehepatic portal hypertension in the rat. Immediate and long-term effects on portal vein and aortic pressure of a graded portal vein stenosis, followed by occlusion of the portal vein and spleno-renal collaterals. Eur Surg Res. 1979;11:89-98.
15. Lin P-W, Shan Y-S. Effects of splenectomy and splenic artery ligation on the portal pressure in portal hypertensive rats. J Surg Res. 1992;53:621-624.
16. Lin P-W, Shan Y-S. Effects of splenectomy on portal pressure in short- and long-term portal hypertensive rats. J Formos Med Assoc. 1992;91:487-490.
17. Diez-Arias JA, Aller MA, Palma MD, Arias JL, Muñiz E, Sánchez M, Arias J. Increased duodenal mucosa infiltration by mast cells in rats with portal hypertension. Dig Surg. 2001;18:34-40.
18. Van Thiel DH, Gavaler JS, Cobb CF, McClain CJ. An evaluation of the respective roles of portosystemic shunting and portal hypertension in rats upon the production of gonadal dysfunction in cirrhosis. Gastroenterology. 1983;85:154-159.
19. López L, Burgos P, Santin LJ, Begega A, Arias J, Lorente L, Arias JL. Portacaval shunt control animals: Physiological consequences derived from the sham operation. Lab Anim. 1997;31:225-230.
20. Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Sem Liver Dis. 2001;21:17-26.
21. McCullough AJ. Update on nonalcoholic fatty liver diasease. J Clin Gastroenterol. 2002;34:255-262.
22. Castilla-Cortazar I, Quiroga I, Prieto J. Insulin-growth factor-I, liver function, and hypogonadism in rats with experimentally induced cirrhosis. Hepatology. 2000;31:1379.